Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Zedenius

Showing results (71-80 of 115) with videos related to

Pageof 12
Sort By:
The American Journal of Surgical Pathology|November 20, 2018
Molecular Profiling of Pheochromocytoma and Abdominal Paraganglioma Stratified by the PASS Algorithm Reveals Chromogranin B as Associated With Histologic Prediction of Malignant BehaviorAdam Stenman, Fredrika Svahn, Mohammad Hojjat-Farsangi, et al.
The Journal of Clinical Endocrinology and Metabolism|October 27, 2005
High frequency of loss of heterozygosity in imprinted, compared with nonimprinted, genomic regions in follicular thyroid carcinomas and atypical adenomasMarta S Sarquis, Frank Weber, Lei Shen, et al.
Endocrine-Related Cancer|July 20, 2007
A PCR-based expression signature of malignancy in follicular thyroid tumorsTheodoros Foukakis, Arief Gusnanto, Amy Y M Au, et al.
Brain Pathology (Zurich, Switzerland)|August 18, 2020
TERT promoter mutations in primary and secondary WHO grade III meningiomaAndrea Daniela Maier, Adam Stenman, Fredrika Svahn, et al.
Endocrine|February 10, 2016
Minimally invasive follicular thyroid carcinomas: prognostic factorsGustav Stenson, Inga-Lena Nilsson, Ninni Mu, et al.
The Journal of Clinical Endocrinology and Metabolism|January 22, 2024
Prevalence, Molecular Landscape, and Clinical Impact of DICER1 and DGCR8 Mutated Follicular-Patterned Thyroid NodulesVincenzo Condello, Anello M Poma, Elisabetta Macerola, et al.
Clinical Epidemiology|April 14, 2011
Breast cancer associated with primary hyperparathyroidism: a nested case control studySophie Norenstedt, Fredrik Granath, Anders Ekbom, et al.
Cancers|September 29, 2019
Clinical Routine <i>TERT</i> Promoter Mutational Screening of Follicular Thyroid Tumors of Uncertain Malignant Potential (FT-UMPs): A Useful Predictor of Metastatic DiseaseMartin Hysek, Johan O Paulsson, Kenbugul Jatta, et al.
The Journal of Clinical Endocrinology and Metabolism|September 13, 2003
Involvement of the PAX8/peroxisome proliferator-activated receptor gamma rearrangement in follicular thyroid tumorsTrisha Dwight, Srinivasan R Thoppe, Theodoros Foukakis, et al.
Virchows Archiv : an International Journal of Pathology|June 4, 2018
TERT promoter mutational screening as a tool to predict malignant behaviour in follicular thyroid tumours-three examples from the clinical routineMartin Hysek, Johan O Paulsson, Na Wang, et al.
Pageof 12

Showing results (71-80 of 115) with videos related to

Sort By:
Pageof 12
The American Journal of Surgical Pathology|November 20, 2018
Molecular Profiling of Pheochromocytoma and Abdominal Paraganglioma Stratified by the PASS Algorithm Reveals Chromogranin B as Associated With Histologic Prediction of Malignant BehaviorAdam Stenman, Fredrika Svahn, Mohammad Hojjat-Farsangi, et al.
The Journal of Clinical Endocrinology and Metabolism|October 27, 2005
High frequency of loss of heterozygosity in imprinted, compared with nonimprinted, genomic regions in follicular thyroid carcinomas and atypical adenomasMarta S Sarquis, Frank Weber, Lei Shen, et al.
Endocrine-Related Cancer|July 20, 2007
A PCR-based expression signature of malignancy in follicular thyroid tumorsTheodoros Foukakis, Arief Gusnanto, Amy Y M Au, et al.
Brain Pathology (Zurich, Switzerland)|August 18, 2020
TERT promoter mutations in primary and secondary WHO grade III meningiomaAndrea Daniela Maier, Adam Stenman, Fredrika Svahn, et al.
Endocrine|February 10, 2016
Minimally invasive follicular thyroid carcinomas: prognostic factorsGustav Stenson, Inga-Lena Nilsson, Ninni Mu, et al.
The Journal of Clinical Endocrinology and Metabolism|January 22, 2024
Prevalence, Molecular Landscape, and Clinical Impact of DICER1 and DGCR8 Mutated Follicular-Patterned Thyroid NodulesVincenzo Condello, Anello M Poma, Elisabetta Macerola, et al.
Clinical Epidemiology|April 14, 2011
Breast cancer associated with primary hyperparathyroidism: a nested case control studySophie Norenstedt, Fredrik Granath, Anders Ekbom, et al.
Cancers|September 29, 2019
Clinical Routine <i>TERT</i> Promoter Mutational Screening of Follicular Thyroid Tumors of Uncertain Malignant Potential (FT-UMPs): A Useful Predictor of Metastatic DiseaseMartin Hysek, Johan O Paulsson, Kenbugul Jatta, et al.
The Journal of Clinical Endocrinology and Metabolism|September 13, 2003
Involvement of the PAX8/peroxisome proliferator-activated receptor gamma rearrangement in follicular thyroid tumorsTrisha Dwight, Srinivasan R Thoppe, Theodoros Foukakis, et al.
Virchows Archiv : an International Journal of Pathology|June 4, 2018
TERT promoter mutational screening as a tool to predict malignant behaviour in follicular thyroid tumours-three examples from the clinical routineMartin Hysek, Johan O Paulsson, Na Wang, et al.
Pageof 12